PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives
Fabio Angeli(University of Insubria), Gianpaolo Reboldi(Ca' Foncello Hospital), Monica Trapasso(University of Insubria), Sara Signorotti(University of Perugia), Marina Pane(University of Perugia), Paolo Verdecchia(Azienda Ospedaliera di Perugia)
Cited by 8
Related Papers
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
|European Journal of Internal Medicine|2020|1.3k
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
|Journal of Hypertension|2014|1k
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
|Hypertension|2004|506
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients
|Hypertension|2016|503